These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11267456)

  • 1. Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression.
    Jordan ML; Chakrabarti P; Luke PP; Shapiro R; Vivas CA; Scantlebury VP; Hakala TR; Fedorek S; Corry RJ
    Transplant Proc; 2001; 33(1-2):1655. PubMed ID: 11267456
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation.
    Boggi U; Vistoli F; Coppelli A; Marchetti P; Rizzo G; Mosca F
    Transplant Proc; 2001; 33(7-8):3201-2. PubMed ID: 11750373
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy.
    Kaufman DB; Leventhal JR; Stuart J; Parker M; Abecassis M; Fryer JP; Stuart FP
    Transplant Proc; 1999; 31(1-2):615-6. PubMed ID: 10083261
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term results of pancreas transplantation under tacrolius immunosuppression.
    Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
    Jordan ML; Chakrabarti P; Luke P; Shapiro R; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 2000 Jan; 69(2):265-71. PubMed ID: 10670637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.
    Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1998 Jun; 30(4):1544-5. PubMed ID: 9636627
    [No Abstract]   [Full Text] [Related]  

  • 8. Modified release tacrolimus in de novo immunosuppression after simultaneous pancreas-kidney transplantation--a first single-center experience.
    Schenker P; Klein T; Krüger B; Claas S; Wunsch A; Traska T; Krämer BK; Viebahn R
    Transplant Proc; 2009; 41(6):2573-5. PubMed ID: 19715977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.
    Ciancio G; Burke G; Viciana A; Ruiz P; Roth D; Khan TF; Montane B; Strauss J; Miller J
    Transplant Proc; 1998 Jun; 30(4):1536-7. PubMed ID: 9636624
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber AO
    Transplant Proc; 2001; 33(1-2):1701-3. PubMed ID: 11267477
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial.
    Bösmüller C; Ollinger R; Sieb M; Weissenbacher A; Schneeberger S; Pratschke J; Margreiter R
    Ann Transplant; 2012 Dec; 17(4):45-51. PubMed ID: 23274323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
    Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R
    Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression.
    Burke GW; Ciancio G; Olson L; Roth D; Miller J
    Transplant Proc; 2001; 33(1-2):1681-3. PubMed ID: 11267467
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil.
    Kahl A; Bechstein WO; Lorenz F; Steinberg J; Pohle C; Kampf D; Müller A; Settmacher U; Neuhaus P; Frei U
    Transplant Proc; 2001; 33(1-2):1694-5. PubMed ID: 11267473
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen.
    Burke GW; Ciancio G; Figueiro J; Olson L; Gomez C; Rosen A; Suzart K; Miller J
    Transplant Proc; 2002 Aug; 34(5):1918-9. PubMed ID: 12176628
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.
    Krämer BK; Krüger B; Mack M; Obed A; Banas B; Paczek L; Schlitt HJ
    Transplant Proc; 2005 May; 37(4):1789-91. PubMed ID: 15919467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group.
    Stratta RJ
    Transplant Proc; 1997; 29(1-2):654-5. PubMed ID: 9123463
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin.
    Schulz T; Martin D; Heimes M; Klempnauer J; Buesing M
    Transplant Proc; 1998 Jun; 30(4):1533-5. PubMed ID: 9636623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.